Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan

Gastroenterology

Volumn 141, Issue 1, 2011, Pages 269-278

  Emmink, Benjamin L ^a   Van Houdt, Winan J ^a   Vries, Robert G ^a   Hoogwater, Frederik J H ^a   Govaert, Klaas M ^a   Verheem, Andre ^a   Nijkamp, Maarten W ^a   Steller, Ernst J A ^a   Jimenez, Connie R ^b   Clevers, Hans ^a   Borel Rinkes, Inne H M ^a   Kranenburg, Onno ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b University of Amsterdam   (Netherlands)

Author keywords

Cancer Stem Cell; Colon Cancer; Drug Resistance; Metastasis; Tumor Progression

Indexed keywords

ALDEHYDE DEHYDROGENASE; IRINOTECAN; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL SELECTION; COLON SURGERY; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; LIVER RESECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMATIC REVIEW; TUMOR XENOGRAFT;

EID: 79960007999     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.03.052     Document Type: Article

References (37)

1. L.G. van der Flier, and H. Clevers Stem cells, self-renewal, and differentiation in the intestinal epithelium Annu Rev Physiol 71 2009 241 260
2. C.A. O'Brien, A. Pollett, and S. Gallinger A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110 (Pubitemid 46067310)
3. L. Ricci-Vitiani, D.G. Lombardi, and E. Pilozzi Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115 (Pubitemid 46067311)
4. M. Todaro, M.P. Alea, and A.B. Di Stefano Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 Cell Stem Cell 1 2007 389 402 (Pubitemid 47506537)
5. L. Vermeulen, M. Todaro, and M.F. de Sousa Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity Proc Natl Acad Sci U S A 105 2008 13427 13432
6. N. Barker, R.A. Ridgway, and J.H. van Es Crypt stem cells as the cells-of-origin of intestinal cancer Nature 457 2009 608 611
7. C.F. Kim, E.L. Jackson, and A.E. Woolfenden Identification of bronchioalveolar stem cells in normal lung and lung cancer Cell 121 2005 823 835 (Pubitemid 40806415)
8. L.Q. Le, T. Shipman, and D.K. Burns Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas Cell Stem Cell 4 2009 453 463
9. M. Perez-Caro, C. Cobaleda, and I. Gonzalez-Herrero Cancer induction by restriction of oncogene expression to the stem cell compartment EMBO J 28 2009 8 20
10. L. Zhu, P. Gibson, and D.S. Currle Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation Nature 457 2009 603 607
11. M. Dean, T. Fojo, and S. Bates Tumour stem cells and drug resistance Nat Rev Cancer 5 2005 275 284 (Pubitemid 40488633)
12. V.S. Donnenberg, and A.D. Donnenberg Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis J Clin Pharmacol 45 2005 872 877 (Pubitemid 41060226)
13. C.E. Eyler, and J.N. Rich Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis J Clin Oncol 26 2008 2839 2845
14. P.C. Hermann, S.L. Huber, and T. Herrler Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 2007 313 323 (Pubitemid 47355323)
15. C. Hirschmann-Jax, A.E. Foster, and G.G. Wulf A distinct "side population" of cells with high drug efflux capacity in human tumor cells Proc Natl Acad Sci U S A 101 2004 14228 14233 (Pubitemid 39305058)
16. X. Li, M.T. Lewis, and J. Huang Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy J Natl Cancer Inst 100 2008 672 679
17. G. Liu, X. Yuan, and Z. Zeng Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma Mol Cancer 5 2006 67
18. S. Ma, T.K. Lee, and B.J. Zheng CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway Oncogene 27 2008 1749 1758 (Pubitemid 351380265)
19. I. Chau, and D. Cunningham Treatment in advanced colorectal cancer: what, when and how? Br J Cancer 100 2009 1704 1719
20. M.R. Alison, R. Poulsom, and M. Brittan Isolation of gut SP cells does not automatically enrich for stem cells Gastroenterology 130 2006 1012 1013 (Pubitemid 43374555)
21. J. Burkert, W.R. Otto, and N.A. Wright Side populations of gastrointestinal cancers are not enriched in stem cells J Pathol 214 2008 564 573 (Pubitemid 351482271)
22. S.J. Dylla, L. Beviglia, and I.K. Park Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy PLoS ONE 3 2008 e2428
23. E.H. Huang, M.J. Hynes, and T. Zhang Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis Cancer Res 69 2009 3382 3389
24. P. Dalerba, S.J. Dylla, and I.K. Park Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci U S A 104 2007 10158 10163 (Pubitemid 47175279)
25. N.F. Smith, W.D. Figg, and A. Sparreboom Pharmacogenetics of irinotecan metabolism and transport: an update Toxicol In Vitro 20 2006 163 175 (Pubitemid 43087700)
26. C. Kosinski, V.S. Li, and A.S. Chan Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors Proc Natl Acad Sci U S A 104 2007 15418 15423 (Pubitemid 47502932)
27. T. Sato, R.G. Vries, and H.J. Snippert Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche Nature 459 2009 262 265
28. M. Dean ABC transporters, drug resistance, and cancer stem cells J Mammary Gland Biol Neoplasia 14 2009 3 9
29. S.R. Alberts, and L.D. Wagman Chemotherapy for colorectal cancer liver metastases Oncologist 13 2008 1063 1073
30. E. Mitry, J.Y. Douillard, and E. Van Cutsem Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials Ann Oncol 15 2004 1013 1017 (Pubitemid 39089776)
31. J.Y. Douillard, D. Cunningham, and A.D. Roth Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial Lancet 355 2000 1041 1047 (Pubitemid 30162806)
32. L. Candeil, I. Gourdier, and D. Peyron ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases Int J Cancer 109 2004 848 854 (Pubitemid 38500741)
33. D.M. Bradshaw, and R.J. Arceci Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance J Clin Oncol 16 1998 3674 3690 (Pubitemid 28506783)
34. S.C. Linn, and G. Giaccone MDR1/P-glycoprotein expression in colorectal cancer Eur J Cancer 31A 1995 1291 1294
35. N. Ikuno, H. Soda, and M. Watanabe Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum J Natl Cancer Inst 87 1995 1876 1883
36. F. Saliba, R. Hagipantelli, and J.L. Misset Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment J Clin Oncol 16 1998 2745 2751 (Pubitemid 28363040)
37. F. Di Fiore, and E. Van Cutsem Acute and long-term gastrointestinal consequences of chemotherapy Best Pract Res Clin Gastroenterol 23 2009 113 124